Absentia Labs

Based in the United States, Absentia Labs is a startup. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences.

Absentia Labs develops AI-driven computational biology models that integrate biological, chemical, and clinical data to predict drug safety and efficacy early in the drug development process, aiming to reduce late-stage failures and accelerate therapeutic innovation.